tiprankstipranks
Aquarius Surgical Technologies Inc. (TSE:ASTI)
:ASTI

Aquarius Surgical Technologies (ASTI) AI Stock Analysis

1 Followers

Top Page

TSE:ASTI

Aquarius Surgical Technologies

(ASTI)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 5.2)
Rating:42Neutral
Price Target:
C$0.01
▲(0.00% Upside)
Action:ReiteratedDate:04/09/26
The score is held down primarily by poor financial performance (declining revenue, ongoing losses, negative equity, and negative cash flows). Technicals are also weak with the stock trading below major moving averages, partially offset by oversold momentum readings. Valuation looks low on P/E, but that provides only limited support given the underlying financial instability.
Positive Factors
Industry Exposure
Aquarius operates in the Medical - Devices industry, a structural sector underpinned by ongoing healthcare demand and long product lifecycles. That exposure can provide a more stable long-term revenue base and lower cyclicality risk if the company can stabilize execution.
Negative Factors
Declining Revenue
Revenue decline of -17.1% combined with a negative net margin (-12.8%) signals weakening demand and persistent unprofitability. Continued top-line contraction erodes operating leverage, limits reinvestment, and makes sustainable margin recovery difficult without structural product or market improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Industry Exposure
Aquarius operates in the Medical - Devices industry, a structural sector underpinned by ongoing healthcare demand and long product lifecycles. That exposure can provide a more stable long-term revenue base and lower cyclicality risk if the company can stabilize execution.
Read all positive factors

Aquarius Surgical Technologies (ASTI) vs. iShares MSCI Canada ETF (EWC)

Aquarius Surgical Technologies Business Overview & Revenue Model

Company Description
Aquarius Surgical Technologies (ASTI) is a pioneering company in the medical device sector, specializing in advanced surgical solutions designed to enhance patient outcomes and streamline surgical procedures. The company focuses on developing inno...
How the Company Makes Money
null...

Aquarius Surgical Technologies Financial Statement Overview

Summary
Very weak fundamentals: declining revenue (-17.1%), negative profitability (net margin -12.8% with negative EBIT/EBITDA margins), negative stockholders’ equity (liabilities exceed assets), and negative operating/free cash flow indicating liquidity strain.
Income Statement
25
Negative
Balance Sheet
20
Very Negative
Cash Flow
30
Negative
BreakdownJun 2025Jun 2023Mar 2022Jun 2020Mar 2019
Income Statement
Total Revenue91.20K205.25K327.66K958.74K393.38K
Gross Profit47.31K132.85K130.30K378.25K161.41K
EBITDA-832.81K-456.62K-611.35K-1.18M-1.24M
Net Income-1.17M-757.66K-859.20K-1.61M-1.59M
Balance Sheet
Total Assets1.95M574.44K894.98K1.66M1.72M
Cash, Cash Equivalents and Short-Term Investments7.56K107.38K158.19K105.19K125.44K
Total Debt6.47M4.04M3.24M2.02M2.02M
Total Liabilities7.72M5.18M4.11M2.35M2.18M
Stockholders Equity-5.77M-4.61M-3.21M-689.15K-453.90K
Cash Flow
Free Cash Flow-383.29K-256.92K-117.38K-1.07M-2.17M
Operating Cash Flow-383.29K-252.56K-112.16K-951.17K-1.35M
Investing Cash Flow-1.80M-4.36K-5.22K-86.99K-818.55K
Financing Cash Flow2.08M242.29K129.59K1.02M1.72M

Aquarius Surgical Technologies Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.01
Price Trends
50DMA
0.01
Negative
100DMA
0.01
Negative
200DMA
0.01
Negative
Market Momentum
MACD
<0.01
Positive
RSI
20.03
Positive
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ASTI, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 20.03 is Positive, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:ASTI.

Aquarius Surgical Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
C$19.70M-5.28106.68%28.59%23.46%
46
Neutral
C$21.47M-29.60-31.12%9.71%-118.02%
46
Neutral
C$329.55M-5.47-85.73%72.03%-1.47%
42
Neutral
C$275.99K0.244.41%-57.16%2.93%
42
Neutral
C$41.62M-1.50-220.14%209.29%35.38%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:ASTI
Aquarius Surgical Technologies
0.01
-0.01
-50.00%
TSE:ASG
Aurora Spine
0.28
-0.02
-8.33%
TSE:IME
Imagin Medical
0.02
0.00
0.00%
TSE:PINK
Perimeter Medical Imaging AI
0.33
-0.07
-17.50%
TSE:PRN
Profound Medical
9.08
2.74
43.22%
TSE:VPT
VentriPoint Diagnostics
0.11
-0.04
-25.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 09, 2026